Paris, 22 November 2012
METACARDIS (Metagenomics in Cardiometabolic Diseases) is a European project coordinated by Inserm that aims to study the role of the gut microbiota in the development of cardiometabolic diseases (CMDs). Thanks to the support of the European Commission, fourteen partners in six European countries will work together over a five-year period to translate the results obtained with novel CMD diagnosis and treatment methods and pave the way for personalised medicine in CMDs. Researchers and clinicians from the Institute of Cardiometabolism and Nutrition (ICAN) will also be involved in the METACARDIS project.
Download the full press release here.
You can also find this press release on EurekAlert! in English - http://www.eurekalert.org/pub_releases/2012-12/ind-mae120412.php
... and French: http://www.eurekalert.org/pub_releases_ml/2012-12/aaft-t120412.php
There is also a more recent press release highlighting a session called 'Inside out at the 2014 AAAS meeting: The impact of gut flora on diabetes and obesity'. Both Karine Clement and Oluf Pedersen (both MetaCardis investigators) feature.
http://www.eurekalert.org/pub_releases/2014-02/ind-ioa021414.php
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement HEALTH-F4-2012-305312.